For research use only. Not for therapeutic Use.
Elinogrel (Cat.No:I011164) is an investigational antiplatelet agent with potential applications in cardiovascular medicine. It functions as a reversible antagonist of the platelet P2Y12 receptor, inhibiting platelet activation and aggregation. Elinogrel may be used for the prevention of blood clot formation in conditions such as acute coronary syndrome. Clinical trials are ongoing to assess its safety and efficacy.
| Catalog Number | I011164 |
| CAS Number | 936500-94-6 |
| Synonyms | 5-Chloro-N-[[[4-[6-Fluoro-1,4-dihydro-7-(methylamino)-2,4-dioxo-3(2H)-quinazolinyl]phenyl]amino]carbonyl]-2-thiophenesulfonamide |
| Molecular Formula | C20H15ClFN5O5S2 |
| Purity | ≥95% |
| Target | P2Y Receptor |
| Solubility | Soluble to 100 mM in DMSO |
| Storage | Store at 4℃ |
| IUPAC Name | 1-(5-chlorothiophen-2-yl)sulfonyl-3-[4-[6-fluoro-7-(methylamino)-2,4-dioxo-1H-quinazolin-3-yl]phenyl]urea |
| InChI | InChI=1S/C20H15ClFN5O5S2/c1-23-15-9-14-12(8-13(15)22)18(28)27(20(30)25-14)11-4-2-10(3-5-11)24-19(29)26-34(31,32)17-7-6-16(21)33-17/h2-9,23H,1H3,(H,25,30)(H2,24,26,29) |
| InChIKey | LGSDFTPAICUONK-UHFFFAOYSA-N |
| SMILES | CNC1=C(C=C2C(=C1)NC(=O)N(C2=O)C3=CC=C(C=C3)NC(=O)NS(=O)(=O)C4=CC=C(S4)Cl)F |
